The somatostatin analogue, octreotide, modifies both steroidogenesis and IGFBP-1 secretion in human luteinizing granulosa cells

Human Reproduction

Volumn 13, Issue 1, 1998, Pages 150-153

  Mimuro, T ^a   Smith, H ^a   Jwashita, M ^b   Illingworth, P J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Insulin like growth factor binding protein 1; Luteinized granulosa cells; Somatostatin; Steroidogenesis

Indexed keywords

CHORIONIC GONADOTROPIN; OCTREOTIDE; PROGESTERONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN DERIVATIVE; STEROID HORMONE;

ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DRUG EFFECT; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEAL CELL; PROGESTERONE RELEASE; PROTEIN SECRETION; STEROIDOGENESIS;

FALLOPIA;

EID: 0031884705     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.1.150     Document Type: Article

References (25)

1. Adashi, E.Y., Resnick, C.E., Hurwitz, A. et al. (1991) Insulin-like growth factors: the ovarian connection. Hum. Reprod., 6, 1213-1219.
2. Andreani, L.C., Lazzarin, N., Pierro, E. et al. (1995) Somatostatin action on rat ovarian steroidogenesis. Hum. Reprod., 10, 1968-1973.
3. Angervo, M., Koistine, R., Suikkari, A.M. and Seppala, M. (1991) Insulin like growth factor binding protein-1 inhibits DNA amplification induced by insulin-like growth factor I in human granulosa-luteal cells. Hum. Reprod., 6, 770-773.
4. Brazeau, P., Vale, W., Burgus, R. et al. (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 179, 77-79.
5. Ehrenborg, E., Larsson, C., Stern, J. et al. (1992) Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGFBP-1) and 3 (IGFBP-3) on chromosome 7. Genomics, 12, 497-502.
6. Ezzat, S., Ren, S.G., Braunstein, G.D. and Melmed, S. (1992) Octreotide stimulates insulin-like growth factor binding protein-1: a potential pituitary-independent mechanism for drug action. J. Clin. Endocrinol. Metab., 75, 1459-1463.
7. Giudice, L.C. (1992) Insulin-like growth factors and ovarian follicular development. Endocr. Rev., 13, 641-669.
8. Hoist, N., Haug, E., Tanbo, T. et al. (1994) Somatostatin in human follicular fluid. Hum. Reprod., 9, 1448-1451.
9. Hoist, N., Jacobsen, M.B., Haug, E. et al. (1995) Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells. Hum. Reprod., 10, 1363-1366.
10. Jalkanen, J., Huhtaniemi, I., Koskimies, A. et al. (1986) In vivo recovery of human chorionic gonadotropin-stimulated cyclic adenosine 3′, 5′monophosphate production in desensitized human granulosa-luteal cells. Fertil. Steril., 46, 920-924.
11. Jalkanen, J., Suikkari, A.M., Koistinen, R. et al. (1989) Regulation of human insulin-like growth factor binding-protein-1 production in human granulosa-luteal cells. J. Clin. Endocrinol. Metab., 69, 1174-1179.
12. Koistinen, R., Suikkari, A.M., Tiitinen, A. et al. (1990) Human granulosa cells contain insulin-like growth factor-binding protein (IGFBP-1) mRNA. Clin. Endocrinol., 32, 635-640.
13. Lamberts, S.W.J. (1988) The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr. Rev., 9, 419-436.
14. Mclntyre, H.D., Marechal, D.J., Deby, G.P. et al. (1992) Immunoreactive somatostatin in the rat ovary. Acta Endocrinol., 126, 553-556.
15. Mon, T., Saito, H., Ohono, Y. et al. (1984) Evidence for existence of somatostatin-like immunoreactivity with molecular heterogeneity in porcine ovaries. Acta Endocrinol., 106, 254-259.
16. Morris, R.S., Stanczyk, F.Z., Carmina, E. et al. (1995) Alteration in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil. Steril., 63, 742-746.
17. Pawelczyk, L.A., Duleba, A.J., Moon, Y.S. and Yuen, B.H. (1993) Sandostatin has no direct effect on ovarian steroidogenesis in vitro. Hum. Reprod., 8, 364-368.
18. Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. and Nesic, J.S. (1990) Inhibitory effect of somatostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome. Lancet, 336, 900-903.
19. Reichlin, S. (1983) Somatostatin. N. Engl. J. Med., 309, 1495-1501.
20. Ren, S.G., Ezzat, S., Melmed, S. and Braunstein, G.D. (1992) Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology, 131, 2479-2481.
21. Rutanen, E. and Pekonen, F. (1991) Assays for IGF binding proteins. Acta Endocrinol., 124, 70-73.
22. Schusdziarra, V. (1983) Somatostatin - physiological and pathophysiological aspects. Scand. J. Gastroenterol., 82, 69-84.
23. Seppala, M., Wahlstrom, T., Koskimies, A.I. et al. (1984) Human preovulatory follicle fluid, luteinized cells of hyperstimulated preovulatory follicles and corpus luteum contain placental protein 12. J. Clin. Endocrinol. Metab., 58, 505-510.
24. Suikkari, A.M., Jalkanen, J., Koistinen, R. et al. (1989) Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein. Endocrinology, 124, 1088-1090.
25. Wolthers, T., Grofte, T., Flyvbjerg, A. et al. (1994) Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by octreotide, a somatostatin analog. J. Clin. Endocrinol. Metab., 78, 141-144.